Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is an investigational combination dentifrice (toothpaste) developed by Church & Dwight, typically formulated with 0.243% sodium fluoride, 5.0% potassium nitrate, and 20% sodium bicarbonate. It is designed for the prevention of dental caries and the treatment of dentin hypersensitivity. Sodium fluoride acts as the primary anticavity agent by promoting the remineralization of tooth enamel and inhibiting the metabolic activity of cariogenic bacteria. Potassium nitrate serves as a desensitizing agent by increasing extracellular potassium ion concentration, which depolarizes and stabilizes dental nerve membranes to block pain transmission. Sodium bicarbonate (baking soda) acts as a mild abrasive for plaque removal and a buffering agent to neutralize acidic plaque environments, further protecting the enamel from demineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + potassium nitrate + sodium bicarbonate.